nad medical device consultancy limited
nad medical device consultancy limited Company Information
Company Number
08377050
Registered Address
19 titan court, laporte way, luton, beds, LU4 8EF
Industry
Research and experimental development on biotechnology
Telephone
-
Next Accounts Due
October 2025
Group Structure
View All
Shareholders
nicola dill 90%
robert dill 10%
nad medical device consultancy limited Estimated Valuation
Pomanda estimates the enterprise value of NAD MEDICAL DEVICE CONSULTANCY LIMITED at £37 based on a Turnover of £38 and 0.97x industry multiple (adjusted for size and gross margin).
nad medical device consultancy limited Estimated Valuation
Pomanda estimates the enterprise value of NAD MEDICAL DEVICE CONSULTANCY LIMITED at £0 based on an EBITDA of £0 and a 3.88x industry multiple (adjusted for size and gross margin).
nad medical device consultancy limited Estimated Valuation
Pomanda estimates the enterprise value of NAD MEDICAL DEVICE CONSULTANCY LIMITED at £22 based on Net Assets of £10 and 2.29x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Nad Medical Device Consultancy Limited Overview
Nad Medical Device Consultancy Limited is a live company located in beds, LU4 8EF with a Companies House number of 08377050. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in January 2013, it's largest shareholder is nicola dill with a 90% stake. Nad Medical Device Consultancy Limited is a established, micro sized company, Pomanda has estimated its turnover at £38.5 with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Nad Medical Device Consultancy Limited Health Check
Pomanda's financial health check has awarded Nad Medical Device Consultancy Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
6 Weak
Size
annual sales of £38.5, make it smaller than the average company (£3.5m)
- Nad Medical Device Consultancy Limited
£3.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a slower rate (14.5%)
- Nad Medical Device Consultancy Limited
14.5% - Industry AVG
Production
with a gross margin of 27%, this company has a higher cost of product (54.4%)
- Nad Medical Device Consultancy Limited
54.4% - Industry AVG
Profitability
an operating margin of 0% make it more profitable than the average company (-14.6%)
- Nad Medical Device Consultancy Limited
-14.6% - Industry AVG
Employees
with 1 employees, this is below the industry average (49)
- Nad Medical Device Consultancy Limited
49 - Industry AVG
Pay Structure
on an average salary of £79.9k, the company has an equivalent pay structure (£79.9k)
- Nad Medical Device Consultancy Limited
£79.9k - Industry AVG
Efficiency
resulting in sales per employee of £38.5, this is less efficient (£121.2k)
- Nad Medical Device Consultancy Limited
£121.2k - Industry AVG
Debtor Days
it gets paid by customers after 94 days, this is later than average (53 days)
- Nad Medical Device Consultancy Limited
53 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Nad Medical Device Consultancy Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Nad Medical Device Consultancy Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Nad Medical Device Consultancy Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Nad Medical Device Consultancy Limited
- - Industry AVG
NAD MEDICAL DEVICE CONSULTANCY LIMITED financials
Nad Medical Device Consultancy Limited's latest turnover from January 2024 is estimated at £39 and the company has net assets of £10. According to their latest financial statements, we estimate that Nad Medical Device Consultancy Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | |||||||||||
| Interest Receivable | |||||||||||
| Pre-Tax Profit | |||||||||||
| Tax | |||||||||||
| Profit After Tax | |||||||||||
| Dividends Paid | |||||||||||
| Retained Profit | |||||||||||
| Employee Costs | |||||||||||
| Number Of Employees | |||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 10 | 10 | 10 | 10 | 10 | 10 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 10 | 10 | 10 | 10 | 10 | 10 | 0 | 0 | 0 | 0 | 0 |
| total assets | 10 | 10 | 10 | 10 | 10 | 10 | 0 | 0 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | 10 | 10 | 10 | 10 | 10 | 10 | 0 | 0 | 0 | 0 | 0 |
| total shareholders funds | 10 | 10 | 10 | 10 | 10 | 10 | 0 | 0 | 0 | 0 | 0 |
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Tax | |||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | |||||||||||
| cash flow from financing | |||||||||||
| cash and cash equivalents | |||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
nad medical device consultancy limited Credit Report and Business Information
Nad Medical Device Consultancy Limited Competitor Analysis
Perform a competitor analysis for nad medical device consultancy limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in LU4 area or any other competitors across 12 key performance metrics.
nad medical device consultancy limited Ownership
NAD MEDICAL DEVICE CONSULTANCY LIMITED group structure
Nad Medical Device Consultancy Limited has no subsidiary companies.
Ultimate parent company
NAD MEDICAL DEVICE CONSULTANCY LIMITED
08377050
nad medical device consultancy limited directors
Nad Medical Device Consultancy Limited currently has 2 directors. The longest serving directors include Mrs Nicola Dill (Jan 2013) and Mrs Nicola Connolly (Jan 2013).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Nicola Dill | United Kingdom | 55 years | Jan 2013 | - | Director |
| Mrs Nicola Connolly | England | 55 years | Jan 2013 | - | Director |
P&L
January 2024turnover
38.5
+11%
operating profit
0
0%
gross margin
27.1%
-4.36%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2024net assets
10
0%
total assets
10
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
nad medical device consultancy limited company details
company number
08377050
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
January 2013
age
11
incorporated
UK
accounts
Dormant
ultimate parent company
previous names
N/A
last accounts submitted
January 2024
address
19 titan court, laporte way, luton, beds, LU4 8EF
accountant
JAMES WALSH ACCOUNTANT LIMITED
auditor
-
nad medical device consultancy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to nad medical device consultancy limited.
nad medical device consultancy limited Companies House Filings - See Documents
| date | description | view/download |
|---|
